S. 4987: Pharmaceutical Investment Oversight and Accountability Act
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2026-07-15 |
| Sponsor | Sen. Warren, Elizabeth [D-MA] |
| Policy area | Health |
| Cosponsors | 2 |
| Latest action | 2026-07-15 — Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. |
| Last updated | 2026-07-30 |
Summary
An official summary for this measure has not been published by Congress. The full text is available on congress.gov.
Cosponsors (2)
| Name | Party / state |
|---|---|
| Rick Scott | R FL (original cosponsor) 2026-07-15 |
| Kirsten E. Gillibrand | D NY (original cosponsor) 2026-07-15 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 4987 are published by Congress on congress.gov.
View S. 4987 on congress.gov →
Frequently asked questions
What is S. 4987?
S. 4987 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Pharmaceutical Investment Oversight and Accountability Act.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 4987 are available on congress.gov.
Bill data: congress.gov API (official congressional records).